ArticleHaematologica2021

Phase I study of selinexor in combination with dexamethasone, ifosfamide, carboplatin, etoposide chemotherapy in patients with relapsed or refractory peripheral T-cell or natural-killer/T-cell lymphoma

Tiffany Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.